Related Experiment Video
Updated: Jun 13, 2026

Methods to Classify Cytoplasmic Foci as Mammalian Stress Granules
Published on: May 12, 2017
The chemotherapeutic agent bortezomib induces the formation of stress granules
Marie-Josée Fournier1, Cristina Gareau, Rachid Mazroui
1Centre de recherche de l'hôpital St-François d'Assise (CHUQ/CRSFA), 10 rue de l'Espinay, Quebec, QC G1L 3L5, Canada. rachid.mazroui@crsfa.ulaval.ca.
Background:
Cytoplasmic stress granules (SGs) are specialized storage sites of untranslated mRNAs whose formation occurs under different stress conditions and is often associated with cell survival. SGs-inducing stresses include radiations, hypoxia, viral infections, and chemical inhibitors of specific translation initiation factors. The FDA-approved drug bortezomib (Velcade(R)) is a peptide boronate inhibitor of the 26S proteasome that is very efficient for the treatment of myelomas and other hematological tumors. Solid tumors are largely refractory to bortezomib. In the present study, we investigated the formation of SGs following bortezomib treatment.
Results:
We show that bortezomib efficiently induces the formation of SGs in cancer cells. This process involves the phosphorylation of translation initiation factor eIF2alpha by heme-regulated inhibitor kinase (HRI). Depletion of HRI prevents bortezomib-induced formation of SGs and promotes apoptosis.
Conclusions:
This is the first study describing the formation of SGs by a chemotherapeutic compound. We speculate that the activation of HRI and the formation of SGs might constitute a mechanism by which cancer cells resist bortezomib-mediated apoptosis.
Insights
Bortezomib triggers stress granule formation in cancer cells, involving heme-regulated inhibitor kinase (HRI). This SG formation may be a resistance mechanism against bortezomib-induced cell death.
Area of Science:
- Cell Biology
- Cancer Research
- Pharmacology
Background:
- Cytoplasmic stress granules (SGs) sequester untranslated mRNAs, aiding cell survival under stress.
- Stress conditions like hypoxia and viral infections induce SG formation.
- Bortezomib, a proteasome inhibitor, treats hematological tumors but is less effective against solid tumors.
Purpose of the Study:
- Investigate stress granule formation induced by bortezomib treatment.
- Explore the role of heme-regulated inhibitor kinase (HRI) in this process.
- Determine the implications of SG formation for cancer cell survival under bortezomib therapy.
Main Methods:
- Treatment of cancer cells with bortezomib.
- Analysis of stress granule formation.
- Investigation of eIF2alpha phosphorylation and HRI activity.
- HRI depletion experiments.
Main Results:
- Bortezomib effectively induces stress granule formation in cancer cells.
- Heme-regulated inhibitor kinase (HRI) mediates bortezomib-induced SG formation via eIF2alpha phosphorylation.
- Depletion of HRI inhibits SG formation and enhances apoptosis.
Conclusions:
- Bortezomib is the first chemotherapeutic agent shown to induce stress granules.
- HRI activation and subsequent SG formation may represent a cancer cell resistance mechanism against bortezomib.
- Understanding this pathway could inform strategies to overcome bortezomib resistance.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Other Stress Responses in Bacteria
Regulation of the Unfolded Protein Response
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...

